Ankyrin repeat and ubiquitin domain-containing 1 (ANKUB1) is a protein encoded by the ANKUB1 gene in humans. This protein is characterized by the presence of two distinct domains: an ankyrin repeat domain and a ubiquitin domain. The ankyrin repeat is a 33-amino acid motif commonly involved in protein-protein interactions, and these repeats are often found in proteins that play roles in various cellular processes including signaling, cell cycle control, and transcriptional regulation. The ubiquitin domain signifies the potential involvement of ANKUB1 in ubiquitination, a post-translational modification process where ubiquitin, a small regulatory protein, is attached to substrate proteins, often targeting them for degradation by the proteasome, altering their cellular location, affecting their activity, or promoting or preventing protein interactions.
The specific functions of ANKUB1 are not as well-characterized as some other proteins, but based on its structural domains, it is likely involved in the regulation of protein turnover and may serve as an adapter or scaffold protein that brings other proteins together to form functional complexes. Its ankyrin repeats suggest that it has the capacity for protein binding, potentially influencing the stability, localization, or activity of its interaction partners.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, potentially impacting protein degradation processes involving ANKUB1. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 inhibits the ubiquitin-activating enzyme E1, potentially affecting ubiquitination processes related to ANKUB1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, potentially affecting gene expression, including that of ANKUB1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB signaling can be regulated by ubiquitination; inhibitors might indirectly impact ANKUB1 function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
HSP90 inhibitors can disrupt protein folding and stability, potentially affecting ANKUB1-associated proteins. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Inhibiting JAK/STAT signaling might indirectly influence ANKUB1 if it's involved in these pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine inhibits autophagy, which could indirectly affect ANKUB1 if it's involved in autophagic processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibitors of the PI3K/Akt pathway might impact signaling pathways relevant to ANKUB1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can impact protein synthesis and potentially influence ANKUB1 functions. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits lysosomal function, which could impact cellular pathways involving ANKUB1. |